Neuronetics (STIM) Stock Price, Quote, News & History

Comments

Neuronetics Inc (STIM) Stock Price, Quote, News & History

STIMNASDAQ

Trade with Public

$1.42

0.021.43%

At close: Apr 17, 5:00 PM EST

$1.43

0.010.70%

After Hours: Apr 17, 6:57 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.42

Close

$1.42

Volume / Avg.

1.13M / 2.21M

Day Range

$1.39 - $1.51

52 Wk Range

0.80 - 4.85

Market Cap

$99.07M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

23.15%

Days to Cover

3.39

Recent Neuronetics Inc News

Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan

This week's deal activity spans gaming, healthcare, energy, and private equity, with activist sales pushes and a slew of bankruptcies.

Caroline Ryan

Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On?

Neuronetics shares jumped 41% in after-hours trading following strong preliminary fourth-quarter 2025 revenue results.

Mohd Haider

Retractable Technologies And 2 Other Penny Stocks Executives Are Buying

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-20.37M

Investing Cash Flow (TTM)

-801.00K

Financing Cash Flow (TTM)

35.85M

Free Cash Flow (TTM)

-21.18M

Capital Expenditure (TTM)

-801.00K

Net Change in Cash (TTM)

14.68M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$161.79M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.62

PB Ratio (TTM)

4.34

Earnings Yield % (TTM)

-42.29%

Earnings Yield % (FWD)

-33.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.32

Company Debt

Total Debt

$65.81M

LT Debt

$65.81M

LT Debt Issuance (TTM)

$10.00M

LT Debt Repayment (TTM)

-$211.00K

Total Cash

$28.13M

Debt to Equity

4.04

Issuance of Debt (TTM)

$9.79M

Repayment of Debt (TTM)

-$211.00K

Key Statistics

Open

$1.42

Close

$1.42

Volume / Avg.

1.13M / 2.21M

Day Range

$1.39 - $1.51

52 Wk Range

0.80 - 4.85

Market Cap

$99.07M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

23.15%

Days to Cover

3.39

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Ad...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Neuronetics (STIM) stock?

A

You can purchase shares of Neuronetics (NASDAQ:STIM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Neuronetics (STIM) competitors?

A

Other companies in Neuronetics’s space includes: LENSAR Inc (NASDAQ:LNSR), Baird Medical Investment Holdings Ltd (NASDAQ:BDMD), QT Imaging Holdings Inc (NASDAQ:QTI), Odysight ai Inc (NASDAQ:ODYS) and Fractyl Health Inc (NASDAQ:GUTS).

Q

What is the forecast, or price target, for Neuronetics (STIM) stock?

A

Neuronetics has a consensus price target of $5.25.

Q

What is the current price for Neuronetics (STIM)?

A

The stock price for Neuronetics (NASDAQ: STIM) is $1.43 last updated April 17, 2026 at 6:57 PM EDT.

Q

Does Neuronetics (STIM) pay a dividend?

A

There are no upcoming dividends for Neuronetics.

Q

When is Neuronetics (NASDAQ:STIM) reporting earnings?

A

Neuronetics does not have any upcoming earnings scheduled.

Q

Is Neuronetics (STIM) going to split?

A

There is no upcoming split for Neuronetics.

Q

What sector and industry does Neuronetics (STIM) operate in?

A

Neuronetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch

Baird Medical Investment Holdings Ltd

NASDAQ:BDMD

$1.82

3.41%

QT Imaging Holdings Inc

NRXS

Key Statistics

Open

$1.42

Close

$1.42

Volume / Avg.

1.13M / 2.21M

Day Range

$1.39 - $1.51

52 Wk Range

0.80 - 4.85

Market Cap

$99.07M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

23.15%

Days to Cover

3.39

Recent Neuronetics Inc News

Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan

This week's deal activity spans gaming, healthcare, energy, and private equity, with activist sales pushes and a slew of bankruptcies.

Caroline Ryan

Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On?

Neuronetics shares jumped 41% in after-hours trading following strong preliminary fourth-quarter 2025 revenue results.

Mohd Haider

Retractable Technologies And 2 Other Penny Stocks Executives Are Buying

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-20.37M

Investing Cash Flow (TTM)

-801.00K

Financing Cash Flow (TTM)

35.85M

Free Cash Flow (TTM)

-21.18M

Capital Expenditure (TTM)

-801.00K

Net Change in Cash (TTM)

14.68M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$161.79M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.62

PB Ratio (TTM)

4.34

Earnings Yield % (TTM)

-42.29%

Earnings Yield % (FWD)

-33.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.32

Company Debt

Total Debt

$65.81M

LT Debt

$65.81M

LT Debt Issuance (TTM)

$10.00M

LT Debt Repayment (TTM)

-$211.00K

Total Cash

$28.13M

Debt to Equity

4.04

Issuance of Debt (TTM)

$9.79M

Repayment of Debt (TTM)

-$211.00K

Key Statistics

Open

$1.42

Close

$1.42

Volume / Avg.

1.13M / 2.21M

Day Range

$1.39 - $1.51

52 Wk Range

0.80 - 4.85

Market Cap

$99.07M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

23.15%

Days to Cover

3.39

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Ad...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry